Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...
Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...
Even Kennedy acknowledges that there isn’t robust scientific data to support the use of these peptides.
Unlike tablets, which stay inside the body of the person taking them, topical drugs are absorbed through the skin - and they ...
10don MSN
The stress hormone linked to tumour growth – and how small daily habits can keep it in check
New research suggests chronic stress may influence how cancer behaves ...
The GLP‑1 beverage market is accelerating fast, with brands innovating in hydration, protein, fibre and collagen to meet soaring consumer demand. Discover the growth forecasts, key ingredients, and ...
Influencers and celebrities are using unapproved peptide therapies. What does the science say about them?
The use of testosterone is rising rapidly among Swedish men, and online the hormone is often sold as an elixir of masculinity ...
The boy’s father, Arturo Bazan, adoptive mother Dulce Bazan and older brother Carlos Hernandez-Bazan, 25, are charged with child abuse and torture.
Everyday Health on MSN
GLP-1s May Cause Hair Thinning in the First Year — But It’s Likely Temporary
A new study confirms that people taking GLP-1s are more likely to experience hair loss. The good news? It’s probably reversible. Here’s how to deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results